1.14.20.13	additional information	no marked effect on enzyme activity by addition of NAD+, NADH, NADP+, NADPH, ATP + MgSO4, FAD, FMN, pyrroloquinoline quinone, acetyl-CoA, 6,7-dimethyl-5,6,7,8-tetrahydrofolate, phenazine methosulfate, 2,6-dichlorophenolindophenol, cytochrome c and H2O2	2	
1.14.20.13	additional information	synthesis and inhibitory potencies of substrate analogues, overview. No inhibition by substrate analogues 1-methylpiperidin-4-yl 2-phenylacetate, 8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-phenylpropanoate, and 8-oxabicyclo[3.2.1]octan-3-yl 2-phenylacetate	2	
1.14.20.13	Mg2+	5 mM, 14% inhibition	6	
1.14.20.13	Mn2+	0.4 mM, 95% inhibition	11	
1.14.20.13	Zn2+	0.4 mM, 100% inhibition	14	
1.14.20.13	Zn2+	5 mM, 66% inhibition	14	
1.14.20.13	Ca2+	5 mM, 100% inhibition	15	
1.14.20.13	Cu2+	0.4 mM, 100% inhibition	19	
1.14.20.13	Cu2+	5 mM, 100% inhibition	19	
1.14.20.13	EDTA	0.1 mM, 67% inhibition	21